X4 Pharmaceuticals stockholders elect R. Keith Woods as director, ratify auditor, approve say-on-pay

X4 Pharmaceuticals, Inc

R. Keith Woods elected with 52.2M for, 29.9M withheld; 53.8M broker non-votes.
Ratification of PwC as auditor: 128.9M for, 6.6M against, 0.4M abstain.
Non-binding say-on-pay approved: 67.8M for, 12.2M against, 2.0M abstain, 53.8M broker non-votes.
All three proposals passed at annual meeting held June 9, 2025.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.